Distributed manufacturing may become the future trend: Pharma Inc

Volumes need to be high to justify relocation of manufacturing; strategic decisions cannot be based on current tariff structure

Indian pharmaceutical companies may have units abroad as part of “distributed manufacturing” across various locations, according to industry veterans.

 

This may come about over the next five to 10 years.

 

There will be more interdependence between research and development (R&D) and manufacturing facilities, but they may not be in close proximity.

 

Speaking at the Indian Pharmaceutical Alliance (IPA) Global Pharmaceutical Quality Summit, Umang Vohra, managing director and global chief executive officer (CEO), Cipla, said manufacturing traditionally used to be concentrated in locations that were economic. At this point in time, countries are trying to be self-sufficient in pharma and